Treatment of Metastatic or High-Risk Solid Cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms20235986
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Improving Cancer Immunotherapy by Targeting Tumor-Induced Immune Suppression

Cancer and Metastasis Reviews
Cancer ResearchOncology
2011English

Resection of the Primary Tumor Improves Survival in Metastatic Breast Cancer by Reducing Overall Tumor Burden

Surgery
Surgery
2013English

Avelumab, an Anti-Pd-L1 Antibody, in Patients With Locally Advanced or Metastatic Breast Cancer: A Phase 1b JAVELIN Solid Tumor Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Pgi15 - Healthcare Resource Utilization (Hcru) in Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer Patients Receiving Second-Line Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The World Cancer Burden: Prevent or Perish.

BMJ
1985English

Stratification of Intermediate-Risk Endometrial Cancer Patients Into Groups at High Risk or Low Risk for Recurrence Based on Tumor Gene Expression Profiles

Clinical Cancer Research
Cancer ResearchOncology
2005English

Treatment of Recurrent Tumor and Radiation Ulcer or Necrosis After Implantation of Radium for 4 Cases of Tongue Cancer.

Japanese Journal of Oral & Maxillofacial Surgery
1986English

Cerebral Venous Sinus Thrombosis in Patients With Metastatic Testicular Cancer During Chemotherapy: Reports of Two Cases

Japanese Journal of Urology
Urology
2017English

Six Cases of Retroperitoneal Tumor

Japanese Journal of Urology
Urology
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy